Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

doi:10.1016/j.breast.2025.104437

Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer

Joyce O'Shaughnessy & Stephanie L. Graff et al. · 2025-03-07

Links

DOI PubMed

Journal

The Breast

Authors

Joyce O'Shaughnessy, Sara M. Tolaney, Denise A. Yardley, Lowell Hart, Pedram Razavi, Peter A. Fasching, Wolfgang Janni, Lee Schwartzberg, Julia Kim, Murat Akdere, Courtney McDermott, Aamir Khakwani, Purnima Pathak, Stephanie L. Graff

Funding

Pathology Novartis Pharmaceuticals Corporation Funding

NCI NIH HHS

P30 CA008748